Skip to main content
FinSpry Logo
FinSpry
GH logo
GH
(NASDAQ)
Guardant Health, Inc.
$160.98-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Guardant Health (GH) Stock Price & Financial Analysis

Guardant Health Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$160.25 - $166.69
52-Week High$176.58
52-Week Low$53.40
Open$166.11
Volume2.04M
Average Volume (3M)2.14M
Market Cap21.45B
Shares Outstanding132.87M
Price to Sales (P/S)18.13
Price to Book (P/B)-96.23
EV/EBITDA-51.92
Revenue (TTM)1.18B
Net Income (TTM)-453.44M
Free Cash Flow (TTM)-240.72M
EPS (TTM)$-3.50
Profit Margin-38.33%
Operating Margin-39.75%
50-Day MA$159.75
200-Day MA$117.71
52-Week Change167.56%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Guardant Health

What is the current stock price for GH?

As of the latest trading session, GH stock trades at $160.98. The 52-week range is $53.40–$176.58, with a day range of $160.25–$166.69.

What is the P/E ratio for GH?

The P/E ratio (Price-to-Earnings) for GH is shown in the Key Statistics section. This valuation metric helps compare Guardant Health, Inc. to industry peers.

Does GH pay dividends?

Guardant Health does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for GH?

Based on 23 analysts, the consensus for GH is Buy.

What is the market cap of GH?

Guardant Health's market capitalization is $21.39B, classifying it as a large-cap company. Guardant Health operates in the Healthcare sector within the Diagnostics & Research industry.